AMN / NEW DELHI
Niti Aayog along with top executives of pharma industry and senior government officials discussed ways to boost domestic manufacturing of Active Pharmaceutical Ingredients (APIs), amid concerns over supply disruption from China due to the COVID-19 outbreak. The meeting, chaired by Niti Aayog CEO Amitabh Kant, came a day after Finance Minister Nirmala Sitharaman said the government will soon announce measures to deal with the impact of the coronavirus outbreak on the domestic industry.
A host of measures were discussed at the meeting yesterday to boost domestic manufacturing of APIs and reduce dependence on their imports from China. The meeting was attended by Pharmaceuticals Department Secretary PD Vaghela, Biocon’s Kiran Mazumdar Shaw, Zydus’ Pankaj Patel and Dr Reddy’s Laboratories’ Satish Reddy.